Free Trial

Oric Pharmaceuticals (ORIC) SEC Filings & 10K Form

Oric Pharmaceuticals logo
$10.77 +0.12 (+1.13%)
Closing price 07/3/2025 02:18 PM Eastern
Extended Trading
$10.78 +0.02 (+0.14%)
As of 07/3/2025 04:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Oric Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/24/2025
5:33 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
3:05 PM
Oric Pharmaceuticals (Filer)
Form 424B3
06/23/2025
7:05 PM
Oric Pharmaceuticals (Issuer)
You Angie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2025
11:15 PM
Oric Pharmaceuticals (Filer)
Form EFFECT
06/13/2025
6:38 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
5:37 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
7:18 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
3:16 PM
Oric Pharmaceuticals (Subject)
Piscitelli Dominic (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/06/2025
11:22 AM
Oric Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
06/05/2025
4:17 PM
Oric Pharmaceuticals (Subject)
SR ONE CAPITAL MANAGEMENT, LLC (Filed by)
Form SCHEDULE 13D
06/04/2025
3:32 PM
Oric Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
05/30/2025
3:35 PM
Oric Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G
05/28/2025
3:42 PM
Oric Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
4:47 PM
Oric Pharmaceuticals (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
8:42 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Oric Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:10 PM
Oric Pharmaceuticals (Filer)
Form DEFA14A
04/23/2025
3:15 PM
Oric Pharmaceuticals (Filer)
Form ARS
03/20/2025
3:25 PM
Oric Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2025
4:27 PM
Kunkel Lori Anne (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:30 AM
FMR LLC (Filed by)
Oric Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:30 AM
Oric Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:43 PM
Dier Mardi (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:44 PM
Heyman Richard A. (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:45 PM
Hoerter Steven L. (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:46 PM
Kunkel Lori Anne (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:47 PM
Oric Pharmaceuticals (Issuer)
You Angie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:41 PM
Chacko Jacob (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:41 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:42 PM
Multani Pratik S (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:21 PM
Chacko Jacob (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:22 PM
Multani Pratik S (Reporting)
Oric Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:23 PM
Oric Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
8:31 PM
Chacko Jacob (Reporting)
Oric Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
8:34 PM
Multani Pratik S (Reporting)
Oric Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
8:29 PM
Oric Pharmaceuticals (Subject)
Piscitelli Dominic (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:54 PM
EcoR1 Capital, LLC (Filed by)
Oric Pharmaceuticals (Subject)
Form SC 13G/A
11/14/2024
4:47 PM
Nextech Crossover I GP S.a r.l. (Filed by)
Oric Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
8:42 AM
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
Oric Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Oric Pharmaceuticals (Subject)
Form SC 13G
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Oric Pharmaceuticals (Subject)
Form SC 13G
08/12/2024
3:20 PM
Oric Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
Trump’s New Order Could Boost Social Security Benefits by 400% (Ad)

If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse... ...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier.

Click here to watch the full presentation before it's too late.
08/12/2024
3:10 PM
Oric Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ORIC) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners